Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 509,412 | 286,668 | 404,954 | 642,970 | 219,130 |
| Marketable Securities | 83,214 | 231,446 | 184,189 | N/A | N/A |
| Receivables | 11,397 | 9,090 | 2,282 | 49 | 71 |
| Other current assets | 15,432 | 7,514 | 9,445 | 4,616 | 2,621 |
| TOTAL | $619,455 | $534,718 | $600,870 | $647,635 | $221,822 |
| Non-Current Assets | |||||
| PPE Net | 70,704 | 64,725 | 55,439 | 48,549 | 44,642 |
| Intangibles | 2,110 | 2,186 | 2,262 | 2,338 | 2,414 |
| Other Non-Current Assets | 42,050 | 8,716 | 35 | 68 | 3,065 |
| TOTAL | $114,864 | $75,627 | $57,736 | $50,955 | $50,121 |
| Total Assets | $734,319 | $610,345 | $658,606 | $698,590 | $271,943 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,162 | 2,819 | 6,326 | 3,196 | 3,125 |
| Accrued Expenses | 23,118 | 32,333 | 25,113 | 12,710 | 11,085 |
| Other current liabilities | 54,247 | 10,000 | 10,000 | 10,000 | 10,000 |
| TOTAL | $85,705 | $46,658 | $42,943 | $29,540 | $26,854 |
| Non-Current Liabilities | |||||
| Long Term Debt | 610 | 633 | 656 | 9,423 | 10,339 |
| Other Non-Current Liabilities | 154,438 | 16,006 | 12,627 | 14,094 | 16,719 |
| TOTAL | $155,048 | $20,749 | $16,631 | $26,336 | $29,808 |
| Total Liabilities | $240,753 | $67,407 | $59,574 | $55,876 | $56,662 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 172,007 | 170,774 | 168,993 | 168,483 | 168,321 |
| Common Shares | 2 | 2 | 2 | 2 | N/A |
| Retained earnings | -456,059 | -400,080 | -335,147 | -287,719 | -244,318 |
| Other shareholders' equity | -309 | -126 | 2 | 0 | 448,312 |
| TOTAL | $493,566 | $542,938 | $599,032 | $642,714 | $215,281 |
| Total Liabilities And Equity | $734,319 | $610,345 | $658,606 | $698,590 | $271,943 |